Tau-based therapies in neurodegeneration: opportunities and challenges
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tau-based therapies in neurodegeneration: opportunities and challenges
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 16, Issue 12, Pages 863-883
Publisher
Springer Nature
Online
2017-10-06
DOI
10.1038/nrd.2017.155
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy
- (2017) Christina Ising et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Petr Novak et al. LANCET NEUROLOGY
- Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy
- (2017) Kiran Yanamandra et al. Science Translational Medicine
- Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
- (2017) Chenjie Xia et al. JAMA Neurology
- Widespread tau seeding activity at early Braak stages
- (2016) Jennifer L. Furman et al. ACTA NEUROPATHOLOGICA
- Challenges, solutions, and recommendations for Alzheimer's disease combination therapy
- (2016) James A. Hendrix et al. Alzheimers & Dementia
- Sodium selenate retards epileptogenesis in acquired epilepsy models reversing changes in protein phosphatase 2A and hyperphosphorylated tau
- (2016) Shi-jie Liu et al. BRAIN
- Regional profiles of the candidate tau PET ligand18F-AV-1451 recapitulate key features of Braak histopathological stages
- (2016) Adam J. Schwarz et al. BRAIN
- Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
- (2016) Rik Ossenkoppele et al. BRAIN
- Tau and tauopathies
- (2016) Thomas Arendt et al. BRAIN RESEARCH BULLETIN
- Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure
- (2016) Xuyu Qian et al. CELL
- The amyloid hypothesis of Alzheimer's disease at 25 years
- (2016) Dennis J Selkoe et al. EMBO Molecular Medicine
- Targeting microglia for the treatment of Alzheimer's Disease
- (2016) Paul D. Wes et al. GLIA
- Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study
- (2016) H. Bea Kuiperij et al. JOURNAL OF ALZHEIMERS DISEASE
- Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner
- (2016) Juan Carlos Polanco et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Dynamics and Turnover of Tau Aggregates in Cultured Cells
- (2016) Jing L. Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pittsburgh Compound-B (PiB) binds amyloid β-protein protofibrils
- (2016) Ghiam Yamin et al. JOURNAL OF NEUROCHEMISTRY
- Brain Aggregates: An EffectiveIn VitroCell Culture System Modeling Neurodegenerative Diseases
- (2016) Misol Ahn et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration
- (2016) E. G. Gentry et al. JOURNAL OF NEUROSCIENCE
- Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression
- (2016) T. Saito et al. JOURNAL OF NEUROSCIENCE
- Does age matter? The impact of rodent age on study outcomes
- (2016) Samuel J Jackson et al. LABORATORY ANIMALS
- Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
- (2016) Serge Gauthier et al. LANCET
- Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy
- (2016) Erin E. Congdon et al. Molecular Neurodegeneration
- Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
- (2016) Erica Barini et al. Molecular Neurodegeneration
- How iPS cells changed the world
- (2016) Megan Scudellari NATURE
- Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
- (2016) Dominik Paquet et al. NATURE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Neuronal activity enhances tau propagation and tau pathology in vivo
- (2016) Jessica W Wu et al. NATURE NEUROSCIENCE
- Pharma pumps up anti-tau Alzheimer pipeline despite first Phase III failure
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Ultrasound treatment of neurological diseases — current and emerging applications
- (2016) Gerhard Leinenga et al. Nature Reviews Neurology
- Curcumin improves tau-induced neuronal dysfunction of nematodes
- (2016) Tomohiro Miyasaka et al. NEUROBIOLOGY OF AGING
- Reduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model
- (2016) Cristian A. Lasagna-Reeves et al. NEURON
- Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss
- (2016) Tara E. Tracy et al. NEURON
- PET Imaging of Tau Deposition in the Aging Human Brain
- (2016) Michael Schöll et al. NEURON
- No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice
- (2016) Annika van Hummel et al. PLoS One
- Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein
- (2016) Yuanwu Ma et al. RNA Biology
- Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice
- (2016) Arne Ittner et al. SCIENCE
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease
- (2016) Matthew R. Brier et al. Science Translational Medicine
- Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin
- (2016) Yu Hu et al. Oncotarget
- Fisetin stimulates autophagic degradation of phosphorylated tau via the activation of TFEB and Nrf2 transcription factors
- (2016) Sunhyo Kim et al. Scientific Reports
- Mobility and subcellular localization of endogenous, gene-edited Tau differs from that of over-expressed human wild-type and P301L mutant Tau
- (2016) Di Xia et al. Scientific Reports
- Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
- (2015) Jens Wagner et al. ACTA NEUROPATHOLOGICA
- Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau
- (2015) Sayuri Taniguchi-Watanabe et al. ACTA NEUROPATHOLOGICA
- Ribosylation triggering Alzheimer's disease-like Tau hyperphosphorylation via activation of CaMKII
- (2015) Yan Wei et al. AGING CELL
- Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
- (2015) Adam C. Kaufman et al. ANNALS OF NEUROLOGY
- Effects of Tau Domain-Specific Antibodies and Intravenous Immunoglobulin on Tau Aggregation and Aggregate Degradation
- (2015) Jose O. Esteves-Villanueva et al. BIOCHEMISTRY
- Pharmacologic Inhibition of 5-Lipoxygenase Improves Memory, Rescues Synaptic Dysfunction, and Ameliorates Tau Pathology in a Transgenic Model of Tauopathy
- (2015) Phillip F. Giannopoulos et al. BIOLOGICAL PSYCHIATRY
- Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick’s disease and fronto-temporal tauopathies
- (2015) Edward Rockenstein et al. BMC NEUROSCIENCE
- Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain
- (2015) Nicole Maphis et al. BRAIN
- Sodium selenate reduces hyperphosphorylated tau and improves outcomes after traumatic brain injury
- (2015) Sandy R. Shultz et al. BRAIN
- Removing endogenous tau does not prevent tau propagation yet reduces its neurotoxicity
- (2015) S. Wegmann et al. EMBO JOURNAL
- NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1: implications in Alzheimer's disease
- (2015) V. Corsetti et al. HUMAN MOLECULAR GENETICS
- miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregationin vivo
- (2015) Pascal Y. Smith et al. HUMAN MOLECULAR GENETICS
- Amyloid Precursor Protein (APP) Metabolites APP Intracellular Fragment (AICD), Aβ42, and Tau in Nuclear Roles
- (2015) Gerhard Multhaup et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Distinct Therapeutic Mechanisms of Tau Antibodies
- (2015) Kristen E. Funk et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Accelerated pericyte degeneration and blood–brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer’s disease
- (2015) Matthew R Halliday et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau
- (2015) Ismael Santa-Maria et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification and characterization of natural antibodies against tau protein in an intravenous immunoglobulin product
- (2015) Lenka Hromadkova et al. JOURNAL OF NEUROIMMUNOLOGY
- Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells
- (2015) M. Usenovic et al. JOURNAL OF NEUROSCIENCE
- Tau Phosphorylation at Serine 396 Residue Is Required for Hippocampal LTD
- (2015) P. Regan et al. JOURNAL OF NEUROSCIENCE
- The Human Tau Interactome: Binding to the Ribonucleoproteome, and Impaired Binding of the Proline-to-Leucine Mutant at Position 301 (P301L) to Chaperones and the Proteasome
- (2015) C. Geeth Gunawardana et al. MOLECULAR & CELLULAR PROTEOMICS
- Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology
- (2015) Lixin Song et al. Molecular Neurodegeneration
- Pharmacologic blockade of 12/15-lipoxygenase ameliorates memory deficits, Aβ and tau neuropathology in the triple-transgenic mice
- (2015) J Chu et al. MOLECULAR PSYCHIATRY
- Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
- (2015) Asami Kondo et al. NATURE
- Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling
- (2015) Natura Myeku et al. NATURE MEDICINE
- Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
- (2015) Sang-Won Min et al. NATURE MEDICINE
- Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice
- (2015) Meaghan Morris et al. NATURE NEUROSCIENCE
- Stem-cell discovery platforms yield first clinical candidates
- (2015) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease
- (2015) Joannee Zumkehr et al. NEUROBIOLOGY OF AGING
- Sustained high levels of neuroprotective, high molecular weight, phosphorylated tau in the longest-lived rodent
- (2015) Miranda E. Orr et al. NEUROBIOLOGY OF AGING
- BAG3 facilitates the clearance of endogenous tau in primary neurons
- (2015) Zhinian Lei et al. NEUROBIOLOGY OF AGING
- Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies
- (2015) Nga Bien-Ly et al. NEURON
- Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
- (2015) Axel Montagne et al. NEURON
- Invited review: Prion-like transmission and spreading of tau pathology
- (2015) Florence Clavaguera et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Protein structural and surface water rearrangement constitute major events in the earliest aggregation stages of tau
- (2015) Anna Pavlova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box?
- (2015) Mark Lawler et al. Public Health Genomics
- Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model
- (2015) Gerhard Leinenga et al. Science Translational Medicine
- Tau immunotherapy for Alzheimer's disease
- (2015) Jan Torleif Pedersen et al. TRENDS IN MOLECULAR MEDICINE
- Truncated tau deregulates synaptic markers in rat model for human tauopathy
- (2015) Santosh Jadhav et al. Frontiers in Cellular Neuroscience
- Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups
- (2015) Yoshiyuki Soeda et al. Nature Communications
- Nontoxic singlet oxygen generator as a therapeutic candidate for treating tauopathies
- (2015) Sahabudeen Sheik Mohideen et al. Scientific Reports
- Intraperitoneal Administration of a Novel TAT-BDNF Peptide Ameliorates Cognitive Impairments via Modulating Multiple Pathways in Two Alzheimer’s Rodent Models
- (2015) Yuanyuan Wu et al. Scientific Reports
- Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β
- (2015) Jun Jiang et al. Scientific Reports
- Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau
- (2015) Katja Hochgräfe et al. Acta Neuropathologica Communications
- Advances in Therapeutics for Neurodegenerative Tauopathies: Moving toward the Specific Targeting of the Most Toxic Tau Species
- (2014) Julia E. Gerson et al. ACS Chemical Neuroscience
- A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity
- (2014) Zeshan Ahmed et al. ACTA NEUROPATHOLOGICA
- Primary age-related tauopathy (PART): a common pathology associated with human aging
- (2014) John F. Crary et al. ACTA NEUROPATHOLOGICA
- Tau reduction prevents disease in a mouse model of Dravet syndrome
- (2014) Ania L. Gheyara et al. ANNALS OF NEUROLOGY
- Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease
- (2014) Ludovic Collin et al. BRAIN
- Intravenous Immunoglobulin Reduces Tau Pathology and Preserves Neuroplastic Gene Expression in the 3xTg Mouse Model of Alzheimer’s Disease
- (2014) Scott Counts et al. Current Alzheimer Research
- Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
- (2014) Hong Xu et al. CURRENT GENE THERAPY
- MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease
- (2014) J. Banzhaf-Strathmann et al. EMBO JOURNAL
- Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity
- (2014) Cliona Stack et al. HUMAN MOLECULAR GENETICS
- Amyloid-β Peptide-specific DARPins as a Novel Class of Potential Therapeutics for Alzheimer Disease
- (2014) Michael Hanenberg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Autophagy by Rapamycin Does Not Protect Oligodendrocytes Against Protein Aggregate Formation and Cell Death Induced by Proteasomal Inhibition
- (2014) Monika Noack et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications
- (2014) L. Chare et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Activity-Dependent Tau Protein Translocation to Excitatory Synapse Is Disrupted by Exposure to Amyloid-Beta Oligomers
- (2014) M. L. Frandemiche et al. JOURNAL OF NEUROSCIENCE
- Tau-Mediated NMDA Receptor Impairment Underlies Dysfunction of a Selectively Vulnerable Network in a Mouse Model of Frontotemporal Dementia
- (2014) Brian A. Warmus et al. JOURNAL OF NEUROSCIENCE
- Specific Calpain Inhibition by Calpastatin Prevents Tauopathy and Neurodegeneration and Restores Normal Lifespan in Tau P301L Mice
- (2014) M. V. Rao et al. JOURNAL OF NEUROSCIENCE
- Loss of MAP Function Leads to Hippocampal Synapse Loss and Deficits in the Morris Water Maze with Aging
- (2014) Q.-L. Ma et al. JOURNAL OF NEUROSCIENCE
- Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
- (2014) Adam L Boxer et al. LANCET NEUROLOGY
- A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
- (2014) Eduardo Tolosa et al. MOVEMENT DISORDERS
- A three-dimensional human neural cell culture model of Alzheimer’s disease
- (2014) Se Hoon Choi et al. NATURE
- A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes
- (2014) Bo Zhang et al. NATURE MEDICINE
- Tau promotes neurodegeneration through global chromatin relaxation
- (2014) Bess Frost et al. NATURE NEUROSCIENCE
- Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases
- (2014) Alberto Lleó et al. Nature Reviews Neurology
- Proteopathic tau seeding predicts tauopathy in vivo
- (2014) B. B. Holmes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
- (2014) Y. J. Yu et al. Science Translational Medicine
- Open questions for Alzheimer’s disease immunotherapy
- (2014) Todd E Golde Alzheimers Research & Therapy
- A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
- (2013) Bruce H. Morimoto et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation
- (2013) Lea Rozenstein-Tsalkovich et al. EXPERIMENTAL NEUROLOGY
- Diaminothiazoles Modify Tau Phosphorylation and Improve the Tauopathy in Mouse Models
- (2013) Xuemei Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Antibody Uptake into Neurons Occurs Primarily via Clathrin-dependent Fcγ Receptor Endocytosis and Is a Prerequisite for Acute Tau Protein Clearance
- (2013) Erin E. Congdon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology
- (2013) Jiaping Gu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PTL-1 regulates neuronal integrity and lifespan in C. elegans
- (2013) Y. L. Chew et al. JOURNAL OF CELL SCIENCE
- Antisense Reduction of Tau in Adult Mice Protects against Seizures
- (2013) S. L. DeVos et al. JOURNAL OF NEUROSCIENCE
- NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy
- (2013) S Quraishe et al. MOLECULAR PSYCHIATRY
- Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
- (2013) Mathias Jucker et al. NATURE
- Ginsenoside Rd attenuates beta-amyloid-induced tau phosphorylation by altering the functional balance of glycogen synthase kinase 3beta and protein phosphatase 2A
- (2013) Ling Li et al. NEUROBIOLOGY OF DISEASE
- Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI
- (2013) S. J. B. Vos et al. NEUROLOGY
- The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Aβ Oligomers through Tau Phosphorylation
- (2013) Georges Mairet-Coello et al. NEURON
- Anti-Tau Antibodies that Block Tau Aggregate Seeding In Vitro Markedly Decrease Pathology and Improve Cognition In Vivo
- (2013) Kiran Yanamandra et al. NEURON
- Blockade of Tau Hyperphosphorylation and Aβ1–42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer’s Disease
- (2013) Valentine Lahmy et al. NEUROPSYCHOPHARMACOLOGY
- Rapamycin Attenuates the Progression of Tau Pathology in P301S Tau Transgenic Mice
- (2013) Sefika Ozcelik et al. PLoS One
- Neurofibrillary tangle-bearing neurons are functionally integrated in cortical circuits in vivo
- (2013) K. V. Kuchibhotla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila
- (2013) Y. Xiong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Brain homogenates from human tauopathies induce tau inclusions in mouse brain
- (2013) Florence Clavaguera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reconsider Alzheimer's disease by the ‘calpain–cathepsin hypothesis’—A perspective review
- (2013) Tetsumori Yamashima PROGRESS IN NEUROBIOLOGY
- Calpain Inhibitor A-705253 Mitigates Alzheimer's Disease–Like Pathology and Cognitive Decline in Aged 3xTgAD Mice
- (2012) Rodrigo Medeiros et al. AMERICAN JOURNAL OF PATHOLOGY
- Antioxidants for Alzheimer Disease
- (2012) Douglas R. Galasko et al. ARCHIVES OF NEUROLOGY
- Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo
- (2012) Erin E. Congdon et al. Autophagy
- Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies
- (2012) David J. Irwin et al. BRAIN
- Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy
- (2012) Véronique Schaeffer et al. BRAIN
- Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach
- (2012) Nadege Zommer et al. Current Alzheimer Research
- Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity
- (2012) Chronis Fatouros et al. HUMAN MOLECULAR GENETICS
- Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease
- (2012) M. Manczak et al. HUMAN MOLECULAR GENETICS
- Inhibition of JNK by a Peptide Inhibitor Reduces Traumatic Brain Injury–Induced Tauopathy in Transgenic Mice
- (2012) Hien T. Tran et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Identification of an Aggregation-Prone Structure of Tau
- (2012) Shana Elbaum-Garfinkle et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Tau Promotes Neurodegeneration via DRP1 Mislocalization In Vivo
- (2012) Brian DuBoff et al. NEURON
- Propagation of Tau Pathology in a Model of Early Alzheimer's Disease
- (2012) Alix de Calignon et al. NEURON
- Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
- (2012) John M Ringman et al. Alzheimers Research & Therapy
- Dual modification of Alzheimer’s disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach
- (2011) Stefani N. Thomas et al. ACTA NEUROPATHOLOGICA
- Tyrosine Nitration within the Proline-Rich Region of Tau in Alzheimer's Disease
- (2011) Juan F. Reyes et al. AMERICAN JOURNAL OF PATHOLOGY
- Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)
- (2011) Illana Gozes CURRENT PHARMACEUTICAL DESIGN
- Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration
- (2011) Xiaoyu Li et al. EMBO JOURNAL
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
- (2011) Juan Manuel Domínguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The frontotemporal dementia mutation R406W blocks tau’s interaction with the membrane in an annexin A2–dependent manner
- (2011) Anne Gauthier-Kemper et al. JOURNAL OF CELL BIOLOGY
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
- (2011) Heiko Braak et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The Many Faces of Tau
- (2011) Meaghan Morris et al. NEURON
- Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
- (2011) Mian Bi et al. PLoS One
- The acetylation of tau inhibits its function and promotes pathological tau aggregation
- (2011) Todd J. Cohen et al. Nature Communications
- Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
- (2010) Lars M. Ittner et al. CELL
- Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
- (2010) Moran Boimel et al. EXPERIMENTAL NEUROLOGY
- Nuclear Tau, a Key Player in Neuronal DNA Protection
- (2010) Audrey Sultan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy
- (2010) K. R. Brunden et al. JOURNAL OF NEUROSCIENCE
- A Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
- (2010) H. Zempel et al. JOURNAL OF NEUROSCIENCE
- Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
- (2010) A. Boutajangout et al. JOURNAL OF NEUROSCIENCE
- Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
- (2010) Moustapha Cissé et al. NATURE
- Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease
- (2010) Lars M. Ittner et al. NATURE REVIEWS NEUROSCIENCE
- MRI is a sensitive marker of subtle white matter pathology in hypoperfused mice
- (2010) Philip R. Holland et al. NEUROBIOLOGY OF AGING
- Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish
- (2010) Frauke van Bebber et al. NEUROBIOLOGY OF DISEASE
- Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
- (2010) Sang-Won Min et al. NEURON
- Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models
- (2010) J. van Eersel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo
- (2010) Vikram Khurana et al. PLoS Genetics
- Structural and functional changes in tau mutant mice neurons are not linked to the presence of NFTs
- (2009) A.B. Rocher et al. EXPERIMENTAL NEUROLOGY
- Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease
- (2009) Lars M. Ittner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Age-related brain pathology in Octodon degu: Blood vessel, white matter and Alzheimer-like pathology
- (2009) Thomas van Groen et al. NEUROBIOLOGY OF AGING
- Experimental Diabetes Mellitus Exacerbates Tau Pathology in a Transgenic Mouse Model of Alzheimer's Disease
- (2009) Yazi D. Ke et al. PLoS One
- Amyloid- and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice
- (2009) V. Rhein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Animal models of Alzheimer's disease and frontotemporal dementia
- (2008) Jürgen Götz et al. NATURE REVIEWS NEUROSCIENCE
- Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia
- (2008) L. M. Ittner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Regulation of Dynein and Kinesin Motor Proteins by Tau
- (2008) R. Dixit et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now